(Q38307876)

2 September 2017

title

DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor (English)

1 reference

2 September 2017

Ying QL

1

1 reference

2 September 2017

Simon SR

series ordinal

2

1 reference

2 September 2017

publication date

1 October 2000

1 reference

American Journal of Respiratory Cell and Molecular Biology

2 September 2017

published in

1 reference

2 September 2017

volume

23

1 reference

2 September 2017

issue

4

1 reference

2 September 2017

page(s)

506-513

1 reference

Heparin-induced conformational change and activation of mucus proteinase inhibitor.

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Functions of the N-terminal domain of secretory leukoprotease inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Inactivation of bronchial mucous proteinase inhibitor by cigarette smoke and phagocyte-derived oxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Alginate, the slime exopolysaccharide of Pseudomonas aeruginosa, binds human leukocyte elastase, retards inhibition by alpha 1-proteinase inhibitor, and accelerates inhibition by secretory leukoprotease inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Peptide conjugation to an in vitro-selected DNA ligand improves enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Pus, deoxyribonucleic acid, and sputum viscosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

New objective criteria for inflammation in bronchial secretions

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Interactions among stimulated human polymorphonuclear leucocytes, released elastase and bronchial antileucoprotease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Modified RNA sequence pools for in vitro selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Highly potent irreversible inhibitors of neutrophil elastase generated by selection from a randomized DNA-valine phosphonate library

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FAJRCMB.23.4.3939

21 January 2018

Identifiers

DOI

10.1165/AJRCMB.23.4.3939

1 reference

2 September 2017

1 reference